Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted anilines as CCR(4) antagonists

Substituted anilines as CCR(4) antagonists

US Patent 11142521 · Granted Oct 12, 2021

Estimated economic value: $87,557,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases2025
Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases2025
Modulators of 5′-nucleotidase, ecto and the use thereof2025
Modulators of 5′-nucleotidase, ecto and the use thereof2025
Azetidinyl-acetamides as CXCR7 inhibitors2025
Azetidinyl-acetamides as CXCR7 inhibitors2025
Parenterally administered immune enhancing drugs2025
Parenterally administered immune enhancing drugs2025
Amorphous and crystalline forms of IDO inhibitors2025
2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds2025
2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds2025
Thiazole compounds and methods of use thereof2025